Switch to:
GuruFocus has detected 7 Warning Signs with Myriad Genetics Inc $MYGN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Myriad Genetics Inc (NAS:MYGN)
EV-to-EBITDA
13.13 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Myriad Genetics Inc's enterprise value is $1,404.8 Mil. Myriad Genetics Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2017 was $107.0 Mil. Therefore, Myriad Genetics Inc's EV/EBITDA ratio for today is 13.13.

MYGN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -161.3   Max: 45.9
Current: 13.12

-161.3
45.9

During the past 13 years, the highest EV/EBITDA Ratio of Myriad Genetics Inc was 45.90. The lowest was -161.30. And the median was 9.60.

MYGN's EV-to-EBITDA is ranked higher than
82% of the 198 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 17.34 vs. MYGN: 13.12 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Myriad Genetics Inc's stock price is $20.70. Myriad Genetics Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2017 was $0.45. Therefore, Myriad Genetics Inc's P/E Ratio for today is 46.00.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Myriad Genetics Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=1404.775/107
=13.13

Myriad Genetics Inc's current Enterprise Value is $1,404.8 Mil.
Myriad Genetics Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2017 was 41.6 (Jun. 2016 ) + 15.4 (Sep. 2016 ) + 27.6 (Dec. 2016 ) + 22.4 (Mar. 2017 ) = $107.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Myriad Genetics Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=20.70/0.45
=46.00

Myriad Genetics Inc's share price for today is $20.70.
Myriad Genetics Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2017 was 0.32 (Jun. 2016 ) + -0.02 (Sep. 2016 ) + 0.09 (Dec. 2016 ) + 0.06 (Mar. 2017 ) = $0.45.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Myriad Genetics Inc Annual Data

Jun07Jun08Jun09Jun10Jun11Jun12Jun13Jun14Jun15Jun16
ev2ebitda -76.2622.9224.657.059.778.577.579.2813.8110.13

Myriad Genetics Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
ev2ebitda 11.8513.3913.8113.5915.3712.4510.139.238.770.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK